Neonc Technologies Holdings, Inc. (NASDAQ:NTHI) Short Interest Down 30.3% in October

Neonc Technologies Holdings, Inc. (NASDAQ:NTHI) was the recipient of a significant drop in short interest during the month of October. As of October 15th, there was short interest totaling 137,800 shares, a drop of 30.3% from the September 30th total of 197,600 shares. Based on an average daily trading volume, of 158,200 shares, the days-to-cover ratio is currently 0.9 days. Currently, 3.3% of the shares of the company are short sold. Currently, 3.3% of the shares of the company are short sold. Based on an average daily trading volume, of 158,200 shares, the days-to-cover ratio is currently 0.9 days.

Neonc Technologies Price Performance

Shares of NTHI stock traded up $0.39 during midday trading on Monday, reaching $10.19. 37,192 shares of the company traded hands, compared to its average volume of 132,173. The firm’s 50 day simple moving average is $9.78 and its two-hundred day simple moving average is $7.12. Neonc Technologies has a 1-year low of $3.20 and a 1-year high of $25.00.

Neonc Technologies (NASDAQ:NTHI) last posted its quarterly earnings results on Monday, August 18th. The company reported ($0.30) earnings per share (EPS) for the quarter.

Wall Street Analysts Forecast Growth

Separately, Weiss Ratings reissued a “sell (e)” rating on shares of Neonc Technologies in a report on Wednesday, October 8th. One investment analyst has rated the stock with a Sell rating, According to data from MarketBeat, the company presently has a consensus rating of “Sell”.

Institutional Investors Weigh In On Neonc Technologies

A number of hedge funds and other institutional investors have recently modified their holdings of NTHI. Bank of America Corp DE acquired a new stake in shares of Neonc Technologies during the 2nd quarter valued at approximately $801,000. Westmount Partners LLC lifted its position in shares of Neonc Technologies by 333.7% during the 2nd quarter. Westmount Partners LLC now owns 73,246 shares of the company’s stock valued at $261,000 after acquiring an additional 56,358 shares during the period. Global Retirement Partners LLC purchased a new position in shares of Neonc Technologies during the 3rd quarter worth approximately $434,000. LVW Advisors LLC purchased a new position in shares of Neonc Technologies during the 2nd quarter worth approximately $108,000. Finally, HighPoint Advisor Group LLC purchased a new position in shares of Neonc Technologies during the 1st quarter worth approximately $290,000.

Neonc Technologies Company Profile

Neonc Technologies Holdings, Inc develops novel molecular technology that provides enhanced targeted delivery of technologies for treating central nervous system diseases. Its lead products in development include NEO100, which is in Phase 2a clinical trials for treating glioblastoma; and NEO212, a covalently conjugated molecule combining the chemotherapeutic drug temozolomide with perillyl alcohol that is completed preclinical testing.